---
title: "Imatinib - Gastrointestinal Stromal Tumor"
sidebar: mydoc_sidebar
permalink: db00619-mesh-d046152-1.html
toc: false 
---


Path ID: `DB00619_MESH_D046152_1`
{% include image.html url="images/db00619-mesh-d046152-1.png" file="db00619-mesh-d046152-1.png" alt="db00619-mesh-d046152-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000068877">MESH:D000068877 </a> | imatinib | Drug |
| <a href="https://identifiers.org/UniProt:P10721">UniProt:P10721 </a> | Mast/stem cell growth factor receptor Kit | Protein |
| <a href="https://identifiers.org/UniProt:P16234">UniProt:P16234 </a> | Platelet-derived growth factor receptor alpha | Protein |
| <a href="https://identifiers.org/GO:0035790">GO:0035790 </a> | platelet-derived growth factor receptor-alpha signaling pathway | BiologicalProcess |
| <a href="https://identifiers.org/GO:0038109">GO:0038109 </a> | Kit signaling pathway | BiologicalProcess |
| <a href="https://identifiers.org/GO:0030154">GO:0030154 </a> | cell differentiation | BiologicalProcess |
| <a href="https://identifiers.org/GO:0008283">GO:0008283 </a> | cell population proliferation | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D002470">MESH:D002470 </a> | Cell Survival | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D046152">MESH:D046152 </a> | Gastrointestinal stromal tumor | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Imatinib | DECREASES ACTIVITY OF | Mast/Stem Cell Growth Factor Receptor Kit |
| Imatinib | DECREASES ACTIVITY OF | Platelet-Derived Growth Factor Receptor Alpha |
| Platelet-Derived Growth Factor Receptor Alpha | POSITIVELY REGULATES | Platelet-Derived Growth Factor Receptor-Alpha Signaling Pathway |
| Platelet-Derived Growth Factor Receptor-Alpha Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Platelet-Derived Growth Factor Receptor-Alpha Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Survival |
| Mast/Stem Cell Growth Factor Receptor Kit | POSITIVELY REGULATES | Kit Signaling Pathway |
| Kit Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Kit Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Survival |
| Kit Signaling Pathway | POSITIVELY CORRELATED WITH | Cell Differentiation |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Gastrointestinal Stromal Tumor |
| Cell Survival | POSITIVELY CORRELATED WITH | Gastrointestinal Stromal Tumor |
| Cell Differentiation | POSITIVELY CORRELATED WITH | Gastrointestinal Stromal Tumor |
|---------|-----------|---------|

Comment: The majority of Gastrointestinal stromal tumor patients have mutations on the KIT or PDGFRA genes (95% of all patients).

Reference: 
  - [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate)
  - [https://en.wikipedia.org/wiki/Imatinib#Gastrointestinal_stromal_tumors](https://en.wikipedia.org/wiki/Imatinib#Gastrointestinal_stromal_tumors)
  - [https://go.drugbank.com/drugs/DB00619#BE0000453](https://go.drugbank.com/drugs/DB00619#BE0000453)
  - [https://go.drugbank.com/drugs/DB00619#BE0000852](https://go.drugbank.com/drugs/DB00619#BE0000852)
